e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Treatment of tuberculosis at times of emerging drug resistance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis
T. Morozova, T. Salina (Saratov, Russian Federation)
Source:
Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Session:
Treatment of tuberculosis at times of emerging drug resistance
Session type:
E-Communication Session
Number:
209
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Morozova, T. Salina (Saratov, Russian Federation). Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 209
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Evaluation of a rapid bactriophage assay for the detection of
mycobacterium tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Comparison of
Mycobacterium tuberculosis
drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Colorimetric assays for rapid drug susceptibility testing of
Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 167s
Year: 2003
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
FluoroType MTB system for the detection of pulmonary tuberculosis
Source: ERJ Open Res, 3 (2) 00113-2016; 10.1183/23120541.00113-2016
Year: 2017
Standardised PCR-based molecular epidemiology of tuberculosis
Source: Eur Respir J 2008; 31: 1077-1084
Year: 2008
Novel approach to species identification of nontuberculous mycobacteria
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
A new integrated PCR and microarray lab-on-chip for rapid MDR tuberculosis diagnosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Gene-based diagnosis of tuberculosis with a new-generation pathogen enrichment technique
Source: Eur Respir J, 55 (3) 1901885; 10.1183/13993003.01885-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept